Q2 and H1 FY27 results: profit and margins rise

Investor Communications View source PDF Explain this filing

ANTHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.8%Reaction day

₹857.00

prior close

₹862.40

announcement price

After-mkt

timing

Nifty Midcap 150market+1.6%+2.2% vs market

Biotechnology peers, median of 5sector+1.9%+1.9% vs sector

On the reaction day the stock moved 2.2 pts more than Nifty Midcap 150 and 1.9 pts more than its Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.9

10m

-1.7

15m

-2.4

30m

-1.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.8+1.6+2.2+1.9+1.9

Next day

+6.4+3.6+2.9+6.7-0.3

+6.8pendingpending+4.7+2.0

—————

15d

—————

UpDownMarket · Nifty Midcap 150Sector · Biotechnology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anthem reported Q2 FY27 operating revenue of ₹594 crore, up 7.9% year on year, with contract research and manufacturing revenue at ₹509 crore. EBITDA rose 24.1% to ₹330 crore and profit after tax rose 21.9% to ₹212 crore; margins reached 50.6% and 32.4%. H1 operating revenue fell 7.2% to ₹1,012 crore, but profit after tax rose 7.2% to ₹331 crore. Net cash was ₹1,538 crore. EBITDA includes other income of ₹59 crore in Q2 and ₹84 crore in H1.

Likely market impact

Strong profit growth, higher margins and net cash support sentiment, though falling H1 revenue and other income in EBITDA temper the positive picture.